We have designed, built, and tested an apparatus used for investigating the biomechanical response of a novel intradural spinal cord stimulator to the simulated physiological movement of the spinal cord within the thecal sac. In this apparatus, the rostral-caudal displacements of an anthropomorphic spinal cord surrogate can be controlled with a resolution of approximately 0.1% of a target value for up to 10 7 lateral movement cycles occurring at a repetition rate of 2 Hz. Using this system, we have been able to determine that the restoring force of the stimulator's suspension system works in concert with the frictional coupling between the electrode array and the surrogate to overcome the 0.42 μN inertial force associated with the lateral motion of the array. The result is a positional stability of the array on the surrogate (in air) of better than 0.2 mm over ∼500 000 movement cycles. Design modifications that might lead to improved physiological performance are discussed. © 2013 AIP Publishing LLC.
I. INTRODUCTION
Our laboratories are developing a novel intradural approach to spinal cord stimulation for the treatment of intractable back and leg pain.
1, 2 The Human Spinal Cord Modulation System (HSCMS), also referred to as the IPatch TM , situates an array of electrodes directly on the pial surface of the spinal cord.
3 By doing so, more selective activation of the targeted dorsal column fibers is achieved compared with that obtained by standard epidural stimulators, because the shunting effects caused by the layer of high conductivity cerebrospinal fluid (CSF) inside the spinal canal can be avoided. 4, 5 The conceptual physical arrangement for the HSCMS is shown in Fig. 1 , which presents a lateral view of the spinal cord surrounded by CSF inside the dura. As seen there, the electrode-bearing implant rests on the dorsal (back-facing) surface of the spinal cord. It is kept gently in place by the soft compliance (ranging from 2 to 60 μN μm −1 ) of the lead loops of the electrodes. 6, 7 The leads exit the thecal sac through the durotomy opening, which is then sealed by a bioresorbable dural cuff, as is the standard practice for durotomy. Fixation of the entire assembly to the encasing vertebra is by a titanium bridge (termed the Oya strap 7 ) that spans the laminectomy. The lead bundle is subsequently connected to an implantable pulse generator, which produces the stimulus signals that the electrodes apply to the spinal cord tissues. A prototype of a characteristic version of this system is shown in full view in Fig. 2(a) , with a close-up of the electrode array on the underside of the implant shown in Fig. 2(b) . The implant is a) Author to whom correspondence should be addressed. Electronic mail: matthew-howard@uiowa.edu made of biocompatible silicone, approximately 16 mm long, 6 mm wide, and 1 mm thick, and has been formed with an ∼4 mm radius of curvature to accommodate the roughly oval shape of the thoracic-level spinal cord. 8 The leads are of 0.1 mm diameter, insulated, 35N LT R Ag-core stranded cables, and the electrodes are flat platinum disks, 0.7 mm in diameter.
As a prelude to the testing protocols that will be needed to establish safety and efficacy of the HSCMS for regulatory purposes, we have carried out several rounds of in vitro, in vivo, and computational studies aimed at investigating the device mechanics, 6, 7 the surgical implantation and spinal fixation procedures, 3, 9 the size of the therapeutic window associated with intradural stimulation, 10, 11 the relevant histological and pathological findings, 12 and the effects of direct spinal cord stimulation on somatosensory evoked potentials. 4, 5 Because of the unique intradural location of the device, we have also carried out magnetic resonance (MR) image-based assessments of the spinal cord morphology 8 and mobility 13, 14 in patients and volunteers, to help define the in situ design and performance requirements that it will have to meet. The mobility measurements were of particular interest, as the HSCMS must remain in place on the spinal cord as it moves within the spinal canal when the patient flexes and twists the spine during normal daily activities, postural changes, etc. While previous studies by several groups provided useful background data on various other aspects of spinal cord motion, [15] [16] [17] [18] [19] [20] [21] our measurements focused specifically on determining the size of the rostral-caudal (i.e., axial) movement of the cord in response to spinal flexion. 13, 14 The overall result was a mean value and standard deviation of (8.5 ± 6.0) mm at the T10/T11 level across a series of 16 volunteers. The lead loops of the device must thus be long enough to accommodate such motions, while still applying sufficient restoring force to the electrode-bearing membrane to keep it from lifting off the spinal cord's surface during such large amplitude excursions. Because of the significant costs associated with in vivo testing of medical devices, and especially those still in the design phase, we sought to develop bench-top instrumentation that would allow us to mimic the most critical aspects of HSCMS implantation on the mobile spinal cord, for rapid yet reliable evaluation of design alternatives and performance characteristics. In what follows we describe a reciprocating motion control system that employs an anthropomorphic surrogate of the human spinal cord for use in HSCMS range-oftravel measurements, lead durability studies, and several other investigations that have been critical in developing an understanding of the device's physical performance in response to its biophysical constraints. Representative data from the use of this system in testing HSCMS prototypes with three different lead loop diameters (8, 10 , and 12 mm) are then presented and discussed. We close with an assessment of the system's overall functionality and a description of plans for future improvements.
II. EXPERIMENTAL ARRANGEMENT

A. Design requirements
Except when tethered because of a disease process or from scar formation, the spinal cord is virtually in continuous motion inside the spinal canal. Even in the otherwise quiescent patient, there are at the very minimum the vascular 22 and CSF-driven 23 pulsations of the cord, which can produce low amplitude (<0.5 mm) oscillatory motions at speeds 24 up to 7 mm s −1 . However, we are concerned here with the dominant larger amplitude motions described above, which are associated with normal patient activity. Therefore, our goals were (1) to build an apparatus that would simulate the reciprocating large amplitude movements of the spinal cord with adjustable speed and range of motion, (2) to make the moving element in that apparatus an anthropomorphic surrogate of adult human spinal cord, and (3) to incorporate a fixture for mounting prototype HSMCS devices on the surrogate spinal cord with adjustability of the degree of compression of the A number of important biophysical considerations guided the design process. First, in healthy adults, trunk flexions of up to 120
• can be achieved 25 over approximately 1 s, hence the nominal stroke rate for reciprocating movements of the spinal cord surrogate should be on the order of 1 Hz, with the ability to operate at faster speeds in order to accelerate testing cycles, increase strain rates, etc. Second, although the spinal cord follows the curve of the spinal canal over its full length, its sub-centimeter range of motion during flexion is small enough to allow approximation by a flat surrogate rather than a curved one. Third, the surrogate spinal cord should have an elastic modulus that closely matches that of actual spinal cord, for accurate simulation of the interaction dynamics between the HSCMS and the living tissues. Finally, because the human body spends roughly as much time oriented vertically as horizontally, the apparatus should be capable in principle of operating in any orientation, in order to simulate various postural positions. The apparatus we built in response to these needs and considerations is described in Subsection II B. 
B. System build-out
Motion controller
The fully assembled test rig is shown in conceptual profile in Fig. 3 (a) and in the full-view photograph of Fig. 3(b) . There are two central features of the apparatus. The first is its ability for precise placement of the HSCMS electrode array at any chosen location on the upper surface of the surrogate spinal cord, which is described in detail in Subsection II B 2. This is enabled by the stage assembly. The second is that it can reliably carry out large numbers (>10 7 ) of repetitions of specific, user-defined spinal cord displacement cycles. The motor, controller, and slide assemblies serve that purpose.
Beginning with the stage assembly, and as per the closeup photo in Fig. 4 , the lead bundle exiting the top of the dural cuff of the HSCMS is fixed inside a clamp at the bottom of a riser rod which provides coarse vertical adjustment for the positioning of the electrode array on the surrogate spinal cord. The riser rod is coupled to a lateral stand-off rod by a post clamp, with the stand-off rod subsequently fixed to a Velmex A15 Series translation stage which provides fine vertical adjustment along the Z axis (resolution of 1 mm of stage travel per turn of the lead screw). Two additional such translation stages provide for similarly precise X-and Y-axis adjustment of the HSCMS location.
Cyclical lateral motion of the surrogate is used to simulate the rostral-caudal movement of the spinal cord within the The motor and gear box (SPG Co., models S9140GEH-V12 and S9DB6B1HA, respectively) are driven by a control module (SPG Co., model SUA401A-V12A) capable of regulating the shaft speed to within 5% of its set point over the range from 15 to 283 rpm (0.25-4.7 Hz). An inductive proximity sensor (Red Lion Controls, model PSAC0000) monitors the rotation of the motor's shaft and signals a digital tachometer (Red Lion Controls, model CUB5R000) that can totalize up to 10 7 counts, i.e., lateral motion cycles. All components of the apparatus are mounted onto a 0.6 × 30 × 40 cm anodized aluminum base plate for stability. Because everything is fixed in place securely, the apparatus could be used in any orientation, but is typically run with the base plate resting on a flat surface.
Spinal cord surrogate
One of the key components of the apparatus is the spinal cord surrogate, shown in Fig. 4 . Described in detail elsewhere, [26] [27] [28] it is of silicone with an oval cross section of 6 mm minor diameter and 10 mm major diameter, and with a length of 6 cm. The silicone formulation used for it has an elastic modulus in the range of 0.41-0.44 MPa, which matches well 26 with that derived from low-strain rate measurements made on ex vivo samples of human spinal cord. As mentioned above, a central support rod passes through it axially to serve as the actuator shaft for the cyclic lateral motions. It consists of a 30 cm length of 16 gauge, 304 stainless steel hypodermic needle tubing, approximately 1.6 mm in outer diameter. It is incorporated into the surrogate by passing it through carefully aligned center holes in the end-caps of the mold into which the silicone mix is poured. After a 12 h cure, the mold components are separated and the surrogate with integral support rod, as shown in Fig. 4 , is ready for installation into the apparatus.
Devices under test
The mechanical performance characteristics of HSCMS prototypes with three different lead-loop diameters, 12 mm, 10 mm, and 8 mm, were investigated in the testing apparatus described above. face, in order to maximize the travel range before its axial tips lifted off the spinal cord surrogate. The investigatory versions of them shown in Fig. 5(b) were of polyetheretherketone (PEEK) tubing, approximately 0.5 mm in diameter and 15 mm long. However, in the clinical version of the HSCMS, any such struts would instead be of a stiff grade of silicone and be incorporated into the structure of the electrode-bearing surface itself. In general, the results from the bench top tests undertaken with these devices were meant to supplement the findings obtained from our ongoing, chronic in vivo trial of implantation of the same devices in sheep.
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C. Testing protocols
Two broad classes of testing were carried out with this apparatus: (1) evaluations of the dynamic stability of the HSCMS on the spinal cord surrogate as the latter was driven in lateral reciprocating motion, and (2) static determinations of the extremes of motion at which the tip of the HSCMS began to lift off the surrogate. Both types of test were done as a function of the compression depth of the lead loops, in order to mimic the naturally occurring changes in dura-spinal cord distance associated with postural shifts and movement of the spine. The dynamic motion studies were typically at a drive rate of 2 Hz, i.e., two complete translational movement cycles of the spinal cord surrogate per second, thus allowing for the accumulation, e.g., of 10 6 cycles in just under six days of run time. Visual observations of the motion sequences, along with video recordings of brief segments (∼10 s each), were made at various intervals to monitor the HSCMS behavior over the course of the translation cycling. As the primary intent here was to confirm overall dynamical stability as opposed to investigating the micromechanics at the HSCMS-surrogate interface, monitoring of this type was adequate. Moreover, if needed, individual frames from the video segments could be captured and magnified for higher resolution (<50 μm) assessment of the HSMCS in situ response, as appropriate. All observations and measurements were archived for subsequent assessment.
III. RESULTS AND DISCUSSION
A. Dynamic stability
After positioning the HSCMS in the stage assembly, reference lines were drawn on the spinal cord surrogate to mark the initial locations of the leading and trailing edges of the electrode-bearing surface. Motor-driven translational movement of the surrogate was then initiated and carried out until at least 300 000 cycles, and typically twice that many, had been achieved. The visual inspections of the HSCMS location relative to the reference lines (as confirmed with the intervals of video monitoring, as mentioned above) revealed that the initial position of the device was maintained on the spinal cord surrogate over the entire test. We estimated that the edge of each reference line could be resolved visually to within roughly 0.2 mm. Hence, the slippage or positional drift of the HSCMS on the spinal cord surrogate would have been less than 0.2 mm over a typical experimental run of ∼500 000 cycles.
It is useful to consider some of the dynamic effects that lead to this level of stability. For a stroke length of 1 cm occurring at 2 Hz, the maximum displacement of 5 mm from the neutral position would be achieved in 0.125 s. The mean speed over that period would be 5 mm/0.125 s = 40 mm s −1 = 0.04 m s −1 , and thus the mean acceleration would be 0.32 m s −2 . The electrode-bearing surface of the HSCMS has a mass of ∼0.13 grams = 1.3 × 10 −4 kg, hence the mean lateral inertial force acting on it during that part of the movement cycle is 0.42 μN. We have independently measured 6, 7 the force exerted by the lead loops on the electrode-bearing surface of the HSCMS as function of loop diameter and compression depth and, for example, the 12 mm device exhibited a compliance of approximately 2.4 μN μm −1 . For a typical compression depth of 5 mm, the resulting force was 11 mN which is >10 4 times the orthogonal inertial force estimated above. This, plus the friction at the (unlubricated) HSCMS/surrogate interface, provided a strong enough coupling to produce the observed stability. In the clinical application, concern for any such coupling strengths will ultimately be overridden by the inevitable scarring of the HSCMS onto the pial surface of the spinal cord.
One of the most significant findings of the stability tests was in regard to the electrical patency of the HSCMS leads. Thin strips of metallic film were placed between the bottom of the HSCMS and the dorsal surface of the surrogate in such a way as to allow interconnection of the electrodes and leads in series, so that the overall input-to-output conductivity of the device could be monitored on an ongoing basis by ohmmeter during testing. In one study with the 10 mm device, in which the range of motion was ±5.25 mm at 2 Hz, the leads maintained electrical continuity over 9.4 million cycles with no indications of impending loss of robustness.
B. Lift-off measurements
The other broad area of application for the test rig was for static determination of the extremes of motion at which the distal tip of the HSCMS began to lift off the surrogate. This is a key performance parameter for the device because repeated lift-off from and re-contact with the spinal cord by the distal tips of the device would likely lead to injury of the pial surface. Table I summarizes the results of the measurements which were done by simply moving the surrogate manually forwards and backwards relative to the center-line of the suspension point until 0.5 mm of lift-off was observed. The data were taken as a function of device type and degree of loop compression, and with and without support struts along the axial edges of the electrode bearing surface. The results show that the support struts extend the range of travel significantly for the 10 and 12 mm devices as the lead loops are compressed, with the findings being more equivocal for the 8 mm device.
The test rig also offered the capability of simulating one of the uncertainties associated with the surgical procedure. In closing the durotomy after implantation of the HSCMS, it is likely that the vertical centerline along the diameter of the lead loops will not intersect the axial midline of the spinal cord, but instead will be offset laterally by perhaps as much as ±5 mm no matter how carefully the dura is dissected. By adjustment of the horizontal position of the HSCMS suspension point using the translation stage, the effects of such offsets on the range of travel before lift-off the distal tips of the device TABLE I. Lift-off of the distal ends of the electrode-bearing surface vs. axial displacement without lateral offset of the device suspension point in the stage assembly. The "-" indicates > 0.5 mm lift at the distal edge of the electrode-bearing patch at zero axial displacement. In these orientations lead loop compression over the center region of the device resulted in lift at the distal edges of the patch.
Maximum axial displacement with ≤0.5 mm lift at distal edge of the electrode bearing surface (positive axial displacement/negative axial displacement, mm) Table II . The data show symmetry of response to positive vs. negative offsets, except at the maximum value of compression for the 12 mm device. (The physiological likelihood of that degree of compression is still under study.)
C. Implications for HSCMS design
The flexibility inherent to the design of the test rig, and the use of precision mechanical components in its construction, make it possible to investigate the performance characteristics of many variants of the HSCMS rapidly and with repeatability. This, in turn, has enabled low cost quantitative evaluation of the workability of device features and has reduced significantly the number of in vivo trials needed for pre-clinical study of HSCMS design options.
While this mechanical testing apparatus performed satisfactorily for its intended purposes, there are a number of potential design improvements that could overcome its existing performance limitations. For instance, the incorporation of a capacitive (or other type of electronic solid state) sensor into the spinal cord surrogate would allow for much finer resolution monitoring of the positional stability of the HSCMS. That, in turn, would enable us to more quantitatively examine the nature of its coupling to the surrogate's surface by revealing, for example, any micron-scale slippage that might be associated with stiction-related effects. A further limitation of the existing apparatus, as noted above, is that the spinal cord surrogate was kept intentionally straight and does not reflect the curvature of the spine. While this is a sufficient approximation for testing axial displacements of the range reported here, there are some individuals with enough spinal flexibility to produce flexion-driven axial cord motions 14 of 15-18 mm. Therefore, a more comprehensive version of the apparatus would incorporate a mild curvature into the path followed by the surrogate for greater fidelity to the in vivo situation. Another consideration has to do with the monitoring of the lead conductivity during testing. Our primary interest was in simply observing and verifying electrical continuity over the course of the test duration. An improved version of the apparatus would incorporate fully automated acquisition and analysis of the impedance data in order to identify temporal trends, isolate any transient events, and establish both the short-term and chronic noise floor of the HSCMS. Finally, we are presently building a modified version of the apparatus that incorporates a spinal canal-like chamber around the spinal cord surrogate to enable simulation of the CSF fluid. This will overcome a critical limitation of the existing experimental arrangement, in that it will make it possible to use artificial CSF or other appropriate formulations to evaluate HSCMS dynamic stability in a fluid environment while simultaneously testing for any electrochemically driven degradation of the electrode and lead surfaces.
